Roche unveils Tamiflu program for U.S. firms

06/27/2008 | USA Today · Wall Street Journal, The

Roche Holding AG has launched a program that guarantees supplies of its influenza drug Tamiflu to U.S. companies in the event of a flu pandemic. The program, which requires a minimum order of 2,500 courses of the drug at $6 each, is part of the Swiss drugmaker's strategy to recover from slumping sales of the treatment.

View Full Article in:

USA Today · Wall Street Journal, The

Published in Brief:

SmartBrief Job Listings for Health Care